The Effect of Opioids on P2Y12 Receptor Inhibition in Patients With ST-Elevation Myocardial Infarction Who Are Pre-treated With Crushed Ticagrelor
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT03400267
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT03400267
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT03400267. Randomized; no masking; primary purpose treatment. Start 2018-02-16 (actual); primary completion 2019-10-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of Opioids on P2Y12 Receptor Inhibition in Patients With ST-Elevation Myocardial Infarction Who Are Pre-treated With Crushed Ticagrelor
- Acronym
- ON-TIME 3
- Condition
- STEMI
- Condition
- STEMI - ST Elevation Myocardial Infarction
- Intervention (Drug)
- Paracetamol
- Intervention (Drug)
- Fentanyl
- Lead sponsor
- A.H. Tavenier
- Collaborator
- Isala
Record details
- Record id
cardio:ct-nct03400267- Content hash
72b7b8fc42a0979b4c4849df4cdc39e7c5496d958f25b76516763d3e26616f37